Skip to Content

Vaccines, Volume 12, Issue 6

2024 June - 139 articles

Cover Story: Sublingual vaccines stimulate both mucosal and systemic immune responses, producing antigen-specific s-IgA in mucosae and both IgG and IgA in blood. This protects against viruses in the respiratory tract, like SARS-CoV-2 or influenza. The sublingual vaccine can be self-administered without a needle. Previously, we developed a sublingual vaccine formulated with SARS-CoV-2-RBD antigen and Poly (I:C) in nonhuman primates (NHPs) (doi.org/10.1093/biomethods/bpad017, doi:10.26502/ami.936500113). In the current study, we reported the efficacy and safety of a sublingual vaccine with Influenza HA antigen and Poly (I:C) adjuvant in NHPs. This study also revealed previously unknown mechanisms underlying immune responses mediated by the sublingual vaccine, inducing a “Yin/Yang"-like balance state of immune-enhancing and -suppressive responses. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (139)

  • Commentary
  • Open Access
13 Citations
5,403 Views
22 Pages

Accelerating Global Measles and Rubella Eradication—Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic

  • David N. Durrheim,
  • Jon K. Andrus,
  • Shahina Tabassum,
  • David Githanga and ,
  • Mira Kojouharova and
  • Nadia Talab
  • + 1 author+ 0 author

20 June 2024

No vaccine has been more effective in reducing disease burden, especially in preventing child deaths, than measles-containing vaccine. The return on investment makes measles-containing vaccine one of the most cost-effective public health measures ava...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Editorial
  • Open Access
2 Citations
1,711 Views
2 Pages

20 June 2024

I am delighted and honored to be Guest Editor of this Vaccines Special Issue on measles and rubella elimination [...]

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Review
  • Open Access
5 Citations
7,230 Views
12 Pages

Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries

  • Thomas D. Filardo,
  • Stephen N. Crooke,
  • Bettina Bankamp,
  • Kelley Raines and ,
  • Adria D. Mathis,
  • Tatiana M. Lanzieri,
  • R. Suzanne Beard,
  • Ludmila Perelygina,
  • David E. Sugerman and
  • Paul A. Rota
  • + 5 authors+ 0 author

20 June 2024

Measles and rubella are vaccine-preventable viral diseases and can be prevented by safe, highly effective vaccination with measles- and rubella-containing vaccines. Given the myriad causes of febrile exanthems, laboratory surveillance for both measle...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Article
  • Open Access
9 Citations
5,917 Views
12 Pages

Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in Mongolia

  • José E. Hagan,
  • Stephen N. Crooke,
  • Nyamaa Gunregjav,
  • Sun B. Sowers and ,
  • Sara Mercader,
  • Carole J. Hickman,
  • Mick N. Mulders,
  • Roberta Pastore,
  • Yoshihiro Takashima and
  • Paul A. Rota
  • + 7 authors+ 2 authors

20 June 2024

Mongolia experienced a nationwide measles outbreak during 1 March 2015–31 December 2016, with 49,077 cases reported to the WHO; many were among vaccinated young adults, suggesting a possible role of vaccine failure. Advanced laboratory methods,...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Article
  • Open Access
22 Citations
12,615 Views
20 Pages

Progress and Challenges in Measles and Rubella Elimination in the WHO European Region

  • Mark Muscat,
  • Myriam Ben Mamou,
  • Catharina Reynen-de Kat,
  • Dragan Jankovic and ,
  • José Hagan,
  • Simarjit Singh and
  • Siddhartha Sankar Datta
  • + 2 authors+ 0 author

20 June 2024

The elimination of both measles and rubella remains a priority for all 53 Member States of the World Health Organization (WHO) European Region. To provide an update on the epidemiological status of measles and rubella in the Region, we reviewed surve...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Review
  • Open Access
18 Citations
10,455 Views
18 Pages

20 June 2024

The worldwide elimination of measles and rubella is feasible, but not without overcoming the substantial challenge of vaccine hesitancy. This challenge is complicated by the spread of misinformation and disinformation fueled by rapidly progressing te...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Commentary
  • Open Access
9 Citations
3,036 Views
7 Pages

Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001–2023

  • Peter Strebel,
  • Mark Grabowsky,
  • Edward Hoekstra,
  • Andrea Gay and
  • Stephen Cochi

20 June 2024

This article describes the arc of global measles and rubella elimination since 2000 from the perspective of the founding partners of the Measles Initiative. The Measles Initiative was formed in 2001 as a partnership among the American Red Cross, the...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Commentary
  • Open Access
6 Citations
4,276 Views
7 Pages

The Case for Assessing the Drivers of Measles Vaccine Uptake

  • Jessica Kaufman,
  • Ashleigh Rak,
  • Sophia Vasiliadis,
  • Navrit Brar and ,
  • Eeman Atif,
  • Jennifer White,
  • Margie Danchin and
  • David N. Durrheim
  • + 3 authors+ 0 author

20 June 2024

Global measles cases are on the rise following disruptions to routine immunisation programs during the COVID-19 pandemic, with devastating consequences. According to the World Health Organization, the behavioural and social drivers of vaccination inc...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Article
  • Open Access
3 Citations
2,372 Views
20 Pages

Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data

  • Juana Claus,
  • Thijs ten Doesschate,
  • Esther Taks,
  • Priya A. Debisarun and ,
  • Gaby Smits,
  • Rob van Binnendijk,
  • Fiona van der Klis,
  • Lilly M. Verhagen,
  • Marien I. de Jonge and
  • Janneke H. H. M. van de Wijgert
  • + 7 authors+ 2 authors

20 June 2024

SARS-CoV-2 infections elicit antibodies against the viral spike (S) and nucleocapsid (N) proteins; COVID-19 vaccines against the S-protein only. The BCG-Corona trial, initiated in March 2020 in SARS-CoV-2-naïve Dutch healthcare workers, captured...

(This article belongs to the Section Epidemiology and Vaccination)
  • Review
  • Open Access
8 Citations
6,479 Views
12 Pages

Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities

  • Gloria Rey-Benito,
  • Desirée Pastor,
  • Alvaro Whittembury,
  • Regina Durón and ,
  • Carmelita Pacis-Tirso,
  • Pamela Bravo-Alcántara,
  • Claudia Ortiz and
  • Jon Andrus
  • + 3 authors+ 0 author

20 June 2024

This report reviews national data from all Member States on measles, rubella, and congenital rubella syndrome (CRS) elimination in the Region of the Americas during 2019–2023. It includes an analysis of compliance with vaccination coverage, sur...

(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
  • Article
  • Open Access
8 Citations
3,637 Views
13 Pages

20 June 2024

Early studies have found that the initial COVID-19 vaccination series was protective against severe symptoms and long COVID. However, few studies have explored the association of booster doses on severe disease outcomes and long COVID. This cross-sec...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
5 Citations
7,243 Views
22 Pages

Vaccination with a Human Papillomavirus L2 Multimer Provides Broad Protection against 17 Human Papillomavirus Types in the Mouse Cervicovaginal Challenge Model

  • Zhenwei Han,
  • Shen Wang,
  • Ting Mu,
  • Ping Zhao and ,
  • Lingli Song,
  • Ying Zhang,
  • Jin Zhao,
  • Wen Yin,
  • Yue Wu and
  • Ke Wu
  • + 11 authors+ 6 authors

20 June 2024

Human papillomavirus (HPV) is a prevalent cause of mucosal and cutaneous infections and underlying conditions ranging from benign warts to anogenital and oropharyngeal cancers affecting both males and females, notably cervical cancer. Cervical cancer...

(This article belongs to the Special Issue Human Papillomavirus Vaccine Against Cervical Cancer: New Usage Strategies and Coverage Issues)
  • Article
  • Open Access
2 Citations
2,867 Views
21 Pages

The JMU-SalVac-System: A Novel, Versatile Approach to Oral Live Vaccine Development

  • Andreas Iwanowitsch,
  • Joachim Diessner,
  • Birgit Bergmann and
  • Thomas Rudel

20 June 2024

Salmonella enterica Serovar Typhi Ty21a (Ty21a) is the only licensed oral vaccine against typhoid fever. Due to its excellent safety profile, it has been used as a promising vector strain for the expression of heterologous antigens for mucosal immuni...

(This article belongs to the Special Issue Advances in Oral Vaccine Development)
  • Article
  • Open Access
5 Citations
5,945 Views
15 Pages

SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma

  • Georges Katoul Al Rahbani,
  • Christina Woopen,
  • Marie Dunsche,
  • Undine Proschmann and ,
  • Tjalf Ziemssen and
  • Katja Akgün
  • + 1 author+ 0 author

19 June 2024

Disease-modifying therapies (DMTs) impact the cellular immune response to severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) vaccines in patients with multiple sclerosis (pwMS). In this study, we aim to elucidate the characteristics of...

(This article belongs to the Section Pathogens-Host Immune Boundaries)
  • Article
  • Open Access
10 Citations
3,548 Views
15 Pages

Immune Responses and Protection Profiles in Mice Induced by Subunit Vaccine Candidates Based on the Extracellular Domain Antigen of Respiratory Syncytial Virus G Protein Combined with Different Adjuvants

  • Ruiwen Han,
  • Tangqi Wang,
  • Xueting Cheng,
  • Jialuo Bing and ,
  • Jia Li,
  • Yao Deng,
  • Xuchang Shan,
  • Xuejie Zhang,
  • Donghong Wang and
  • Wenjie Tan
  • + 6 authors+ 1 author

19 June 2024

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease of infants and older people. There is an urgent need for safe and effective vaccines against RSV infection. In this study, we analyzed the effects of the i...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
7 Citations
3,582 Views
14 Pages

Field Trials of Live and Inactivated Camelpox Vaccines in Kazakhstan

  • Muratbay Mambetaliyev,
  • Sanat Kilibayev,
  • Marzhan Kenzhebaeva,
  • Nuraiym Sarsenkulova and ,
  • Shalkar Tabys,
  • Aisulu Valiyeva,
  • Dias Muzarap,
  • Moldir Tuyskanova,
  • Balzhan Myrzakhmetova and
  • Kuandyk Zhugunissov
  • + 10 authors+ 5 authors

19 June 2024

An outbreak of camelpox occurred in the Mangistau region of Kazakhstan in 2019. To control the outbreak of camelpox and to prevent its further spread to other regions, camels were vaccinated using live and inactivated camelpox vaccines produced in Ka...

(This article belongs to the Special Issue Animal Virus Infection, Immunity and Vaccines)
  • Article
  • Open Access
2 Citations
2,273 Views
17 Pages

Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial

  • Xu Han,
  • Mingwei Wei,
  • Xiuyu Zheng,
  • Peng Wan and ,
  • Jie Tang,
  • Lu Zhang,
  • Shupeng Zhang,
  • Hanchi Zhou,
  • Jiayu Lu and
  • Fengcai Zhu
  • + 8 authors+ 3 authors

19 June 2024

Background: Though children infected by SARS-CoV-2 generally experience milder symptoms compared to adults, severe cases can occur. Additionally, children can transmit the virus to others. Therefore, the availability of safe and effective COVID-19 va...

  • Article
  • Open Access
6 Citations
2,220 Views
15 Pages

Hybrid Immunity and the Incidence of SARS-CoV-2 Reinfections during the Omicron Era in Frontline Healthcare Workers

  • Carmen-Daniela Chivu,
  • Maria-Dorina Crăciun,
  • Daniela Pițigoi,
  • Victoria Aramă and ,
  • Monica Luminița Luminos,
  • Gheorghiță Jugulete,
  • Viorela Gabriela Nițescu,
  • Andreea Lescaie,
  • Cătălin Gabriel Apostolescu and
  • Adrian Streinu Cercel
  • + 5 authors+ 0 author

19 June 2024

During the coronavirus disease (COVID-19) pandemic healthcare workers (HCWs) acquired immunity by vaccination or exposure to multiple variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our study is a comparative analysis betwee...

(This article belongs to the Special Issue Influence of Natural and/or Vaccine Immunity on the Dynamics of SARS-CoV-2)
  • Article
  • Open Access
4 Citations
4,411 Views
12 Pages

Water-Soluble and Freezable Aluminum Salt Vaccine Adjuvant

  • Erwin G. Abucayon,
  • Ilya Belikow-Crovetto,
  • Elizabeth Hussin,
  • Jiae Kim and ,
  • Gary R. Matyas,
  • Mangala Rao and
  • Carl R. Alving
  • + 2 authors+ 0 author

19 June 2024

Particulate aluminum salts have long occupied a central place worldwide as inexpensive immunostimulatory adjuvants that enable induction of protective immunity for vaccines. Despite their huge benefits and safety, the particulate structures of alumin...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
9 Citations
3,110 Views
12 Pages

Evaluation of Formalin-Inactivated Vaccine Efficacy against Red Seabream Iridovirus (RSIV) in Laboratory and Field Conditions

  • Joon-Gyu Min,
  • Guk-Hyun Kim,
  • Chong-Han Kim,
  • Woo-Ju Kwon and ,
  • Hyun-Do Jeong and
  • Kwang-Il Kim
  • + 1 author+ 0 author

19 June 2024

Red seabream iridovirus (RSIV) is a major cause of marine fish mortality in Korea, with no effective vaccine available since its first occurrence in the 1990s. This study evaluated the efficacy of a formalin-killed vaccine against RSIV in rock bream...

(This article belongs to the Special Issue Fish Disease Occurrence and Immune Prevention and Control)
  • Article
  • Open Access
1 Citations
2,769 Views
16 Pages

Assessing Predictive Value of SARS-CoV-2 Epitope-Specific CD8+ T-Cell Response in Patients with Severe Symptoms

  • Cristina Martín-Martín,
  • Estefanía Salgado del Riego,
  • Jose R. Vidal Castiñeira,
  • Maria Soledad Zapico-Gonzalez and ,
  • Mercedes Rodríguez-Pérez,
  • Viviana Corte-Iglesias,
  • Maria Laura Saiz,
  • Paula Diaz-Bulnes,
  • Dolores Escudero and
  • Carlos López-Larrea
  • + 6 authors+ 1 author

18 June 2024

Specific T cell responses against SARS-CoV-2 provided an overview of acquired immunity during the pandemic. Anti-SARS-CoV-2 immunity determines the severity of acute illness, but also might be related to the possible persistence of symptoms (long COV...

(This article belongs to the Special Issue Population Immunity and Persistence to SARS-CoV-2 Induced by Infection and Vaccination, Protection against New Infections and Implication for Further Vaccination)
  • Article
  • Open Access
2,369 Views
13 Pages

Real-World Assessment of Recommended COVID-19 Vaccination Waiting Period after Chemotherapy

  • Kai-Wen Cheng,
  • Chi-Hua Yen,
  • Renin Chang,
  • James Cheng-Chung Wei and
  • Shiow-Ing Wang

18 June 2024

There is a knowledge gap concerning the proper timing for COVID-19 vaccination in cancer patients undergoing chemotherapy. We aimed to evaluate the suitability of the guidelines that recommend waiting at least three months after undergoing chemothera...

  • Article
  • Open Access
2 Citations
4,055 Views
25 Pages

S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern

  • Chang-Kyu Heo,
  • Won-Hee Lim,
  • Ki-Beom Moon,
  • Jihyun Yang and ,
  • Sang Jick Kim,
  • Hyun-Soon Kim,
  • Doo-Jin Kim and
  • Eun-Wie Cho
  • + 3 authors+ 0 author

18 June 2024

Approved COVID-19 vaccines primarily induce neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein. However, the emergence of variants of concern with RBD mutations poses challenges to vaccine efficacy...

(This article belongs to the Special Issue COVID Vaccines: Design, Development, and Immune Response Studies)
  • Review
  • Open Access
7 Citations
9,776 Views
17 Pages

18 June 2024

High-grade serous ovarian cancers (HGSOCs) likely consist of poorly differentiated stem-like cells (PDSLCs) and differentiated tumor cells. Conventional therapeutics are incapable of completely eradicating PDSLCs, contributing to disease progression...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Review
  • Open Access
9 Citations
4,815 Views
32 Pages

An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity

  • Emma Chang-Rabley,
  • Menno C. van Zelm,
  • Emily E. Ricotta and
  • Emily S. J. Edwards

18 June 2024

The SARS-CoV-2 pandemic has heightened concerns about immunological protection, especially for individuals with inborn errors of immunity (IEI). While COVID-19 vaccines elicit strong immune responses in healthy individuals, their effectiveness in IEI...

(This article belongs to the Special Issue Influence of Natural and/or Vaccine Immunity on the Dynamics of SARS-CoV-2)
  • Article
  • Open Access
4 Citations
2,642 Views
10 Pages

18 June 2024

Convalescent plasma has been shown to be effective at protecting humans against severe diseases caused by New World (NW) arenaviruses, including Junin virus (JUNV) and Machupo virus (MACV). This plasma contains antibodies against the full complement...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Article
  • Open Access
2 Citations
5,869 Views
15 Pages

Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective Study

  • Yan Zhang,
  • Yuhang Zhang,
  • Binhua Dong,
  • Wenyu Lin and ,
  • Yuxuan Huang,
  • Kelvin Stefan Osafo,
  • Xite Lin,
  • Tingting Jiang,
  • Yu Zhang and
  • Pengming Sun
  • + 6 authors+ 1 author

18 June 2024

During acute respiratory infections, women may concurrently receive human papillomavirus (HPV) and respiratory vaccines, as observed during the coronavirus disease 2019 (COVID-19) pandemic in China. However, few studies have assessed the safety of su...

(This article belongs to the Section Human Papillomavirus Vaccines)
  • Article
  • Open Access
3 Citations
3,932 Views
20 Pages

Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting

  • María Torres-Rufas,
  • Esther F. Vicente-Rabaneda,
  • Laura Cardeñoso,
  • Ainhoa Gutierrez and ,
  • David A. Bong,
  • Cristina Valero-Martínez,
  • José M. Serra López-Matencio,
  • Rosario García-Vicuña,
  • Miguel A. González-Gay and
  • Santos Castañeda
  • + 6 authors+ 1 author

18 June 2024

Novel mechanisms of COVID-19 vaccines raised concern about their potential immunogenicity in patients with rheumatoid arthritis (RA) undergoing immunomodulatory treatments. We designed a retrospective single-center study to investigate their effectiv...

(This article belongs to the Special Issue 2nd Edition: Safety and Autoimmune Response to SARS-CoV-2 Vaccination)
  • Article
  • Open Access
4 Citations
2,986 Views
25 Pages

17 June 2024

Background: It was to understand HPV vaccination patterns, uptake, perceptions, and sexual risk factors in students at a Midwest public university. Participants: Students were enrolled during the spring 2024 semester at the University of Iowa. Method...

(This article belongs to the Special Issue Prevention of Human Papillomavirus and Vaccines Strategies)
  • Review
  • Open Access
20 Citations
5,022 Views
18 Pages

mRNA Technology and Mucosal Immunization

  • Antonio Toniolo,
  • Giuseppe Maccari and
  • Giovanni Camussi

17 June 2024

Current mRNA vaccines are mainly administered via intramuscular injection, which induces good systemic immunity but limited mucosal immunity. Achieving mucosal immunity through mRNA vaccination could diminish pathogen replication at the entry site an...

  • Article
  • Open Access
5 Citations
2,432 Views
15 Pages

Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022

  • Kimberly H. Nguyen,
  • Yingjun Bao,
  • Siyu Chen,
  • Robert A. Bednarczyk and ,
  • Lavanya Vasudevan and
  • Laura Corlin
  • + 1 author+ 0 author

17 June 2024

Given the increase in COVID-19 emergency department visits and hospitalizations during the winter of 2023–2024, identifying groups that have a high prevalence of COVID-19 cases, severity, and long-term symptoms can help increase efforts toward...

(This article belongs to the Special Issue Advancing the Science on Vaccine Hesitancy to Inform Interventions)
  • Article
  • Open Access
1 Citations
2,067 Views
12 Pages

Factors Related to Caregivers’ Intention to Vaccinate Their Elderly Family Members with Major Neurocognitive Disorders against COVID-19

  • Mei-Feng Huang,
  • Yi-Chun Yeh,
  • Tai-Ling Liu,
  • Ray C. Hsiao and ,
  • Cheng-Sheng Chen and
  • Cheng-Fang Yen
  • + 1 author+ 0 author

17 June 2024

Vaccination helps reduce the risk of coronavirus disease 2019 (COVID-19) infection in elderly individuals with major neurocognitive disorders (MNDs). However, some caregivers are hesitant to have their elderly family members with MNDs vaccinated agai...

(This article belongs to the Special Issue Promoting Vaccination in the Post-COVID-19 Era)
  • Article
  • Open Access
9 Citations
5,179 Views
15 Pages

17 June 2024

Influenza viruses can cause highly infectious respiratory diseases, posing noteworthy epidemic and pandemic threats. Vaccination is the most cost-effective intervention to prevent influenza and its complications. However, reliance on embryonic chicke...

(This article belongs to the Special Issue Advances in Influenza Virus Vaccines)
  • Article
  • Open Access
13 Citations
4,903 Views
12 Pages

Lipid Nanoparticles Outperform Electroporation in Delivering Therapeutic HPV DNA Vaccines

  • Mingzhu Li,
  • Lei Liu,
  • Xiaoli Li,
  • Jingran Li and ,
  • Chao Zhao,
  • Yun Zhao,
  • Xiaopeng Zhang,
  • Panpan He,
  • Xiaoyu Wu and
  • Lihui Wei
  • + 8 authors+ 3 authors

17 June 2024

Therapeutic HPV vaccines that induce potent HPV-specific cellular immunity and eliminate pre-existing infections remain elusive. Among various candidates under development, those based on DNA constructs are considered promising because of their safet...

  • Article
  • Open Access
5 Citations
3,737 Views
24 Pages

Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study

  • Joaquín Sáez-Peñataro,
  • Gonzalo Calvo,
  • Juan Bascuas,
  • Maria Mar Mosquera and ,
  • Maria Ángeles Marcos,
  • Natalia Egri and
  • Ferran Torres
  • + 2 authors+ 0 author

17 June 2024

Enhancing our comprehension of mRNA vaccines may facilitate the future design of novel vaccines aimed at augmenting immune protection while minimising reactogenic responses. Before this design is carried out, it is important to determine whether adap...

  • Review
  • Open Access
10 Citations
6,433 Views
11 Pages

Advances in Nucleic Acid Universal Influenza Vaccines

  • Liang Xu,
  • Weigang Ren,
  • Qin Wang and
  • Junwei Li

17 June 2024

Currently, vaccination with influenza vaccines is still an effective strategy to prevent infection by seasonal influenza virus in spite of some drawbacks with them. However, due to the rapid evolution of influenza viruses, including seasonal influenz...

(This article belongs to the Special Issue Feature Papers of DNA and mRNA Vaccines)
  • Article
  • Open Access
2 Citations
2,654 Views
13 Pages

SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV

  • Simona Ruta,
  • Corneliu Petru Popescu,
  • Lilia Matei,
  • Camelia Grancea and ,
  • Adrian Marius Paun,
  • Cristiana Oprea and
  • Camelia Sultana
  • + 2 authors+ 0 author

16 June 2024

Immunosuppressed individuals, such as people living with HIV (PLWH), remain vulnerable to severe COVID-19. We analyzed the persistence of specific SARS-CoV-2 humoral and cellular immune responses in a retrospective, cross-sectional study in PLWH on a...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
  • Article
  • Open Access
3 Citations
2,393 Views
16 Pages

COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia

  • Holly Wang,
  • Lisa Grech,
  • Jennifer Wong,
  • David Hoffman and ,
  • Barbora de Courten,
  • Brett Sillars,
  • Mark Savage,
  • Alastair Kwok,
  • Mike Nguyen and
  • on behalf of the DIABVACCS Investigators
  • + 8 authors+ 3 authors

16 June 2024

Background: This study explored vaccination hesitancy, diabetes-specific COVID-19 vaccination concerns, and whether they predicted vaccination uptake in people with diabetes. Methods: Quantitative, cross-sectional, and predictive approaches were used...

(This article belongs to the Collection Factors Associated with Vaccine Hesitancy)
  • Article
  • Open Access
9 Citations
4,631 Views
36 Pages

Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response

  • Jan M. Sobczak,
  • Irena Barkovska,
  • Ina Balke,
  • Dominik A. Rothen and ,
  • Mona O. Mohsen,
  • Dace Skrastina,
  • Anete Ogrina,
  • Byron Martina,
  • Juris Jansons and
  • Andris Zeltins
  • + 8 authors+ 3 authors

14 June 2024

T help (Th), stimulation of toll-like receptors (pathogen-associated molecular patterns, PAMPs), and antigen organization and repetitiveness (pathogen-associated structural patterns, PASPs) were shown numerous times to be important in driving B-cell...

  • Review
  • Open Access
4 Citations
6,089 Views
16 Pages

A Narrative Review on the Promising Potential of Graphene in Vaccine Design: Evaluating the Benefits and Drawbacks of Carbon Nanoplates in Nanovaccine Production

  • Hadi Zare-Zardini,
  • Elham Saberian,
  • Andrej Jenča,
  • Andrej Jenča and ,
  • Adriána Petrášová and
  • Janka Jenčová
  • + 1 author+ 0 author

14 June 2024

Graphene, a two-dimensional material consisting of a single layer of carbon atoms arranged in a honeycomb lattice, has shown great potential in various fields, including biomedicine. When it comes to vaccine development, graphene can offer several ad...

  • Article
  • Open Access
14 Citations
11,184 Views
15 Pages

mRNA Vaccine for Alzheimer’s Disease: Pilot Study

  • Armine Hovakimyan,
  • Garri Chilingaryan,
  • Olga King,
  • Joia Kai Capocchi and ,
  • Jean Paul Chadarevian,
  • Hayk Davtyan,
  • Roman Kniazev,
  • Michael G. Agadjanyan and
  • Anahit Ghochikyan
  • + 4 authors+ 0 author

14 June 2024

The escalating global healthcare challenge posed by Alzheimer’s Disease (AD) and compounded by the lack of effective treatments emphasizes the urgent need for innovative approaches to combat this devastating disease. Currently, passive and acti...

(This article belongs to the Special Issue Feature Papers of DNA and mRNA Vaccines)
  • Article
  • Open Access
3,946 Views
24 Pages

COVID-19 Vaccination in Pregnancy: Pilot Study of Plasma MicroRNAs Associated with Inflammatory Cytokines after COVID-19 mRNA Vaccination

  • Ching-Ju Shen,
  • Yen-Pin Lin,
  • Wei-Chun Chen,
  • Mei-Hsiu Cheng and ,
  • Jun-Jie Hong,
  • Shu-Yu Hu,
  • Ching-Fen Shen and
  • Chao-Min Cheng
  • + 3 authors+ 0 author

14 June 2024

Background: The impact of mRNA COVID-19 vaccines on the immunological profiles of pregnant women remains a crucial area of study. This research aims to explore the specific immunological changes triggered by these vaccines in this demographic. Method...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
4 Citations
2,925 Views
15 Pages

Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study

  • Amy Keane,
  • Ashley Tippett,
  • Elizabeth Grace Taylor,
  • Olivia Reese and ,
  • Luis Salazar,
  • Khalel De Castro,
  • Chris Choi,
  • Caroline Ciric,
  • Meg Taylor and
  • Evan J. Anderson
  • + 16 authors+ 11 authors

13 June 2024

It is important to understand real-world BNT162b2 COVID-19 vaccine effectiveness (VE), especially among racial and ethnic minority groups. We performed a test-negative case-control study to measure BNT162b2 COVID-19 VE in the prevention of COVID-19-a...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Systematic Review
  • Open Access
6 Citations
8,107 Views
18 Pages

ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination—A Systematic Review

  • Kinga Łysak,
  • Agata Walulik,
  • Michał Błaszkiewicz and
  • Krzysztof Gomułka

13 June 2024

As vaccinations against the SARS-CoV-2 virus have become a crucial tool in controlling the spread of the disease, reports of rare health complications have emerged, including new-onset antineutrophil cytoplasmic autoantibodies (ANCA)-associated vascu...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
5 Citations
4,416 Views
19 Pages

Understanding COVID-19 Vaccine Acceptance among Healthcare Workers in Indonesia: Lessons from Multi-Site Survey

  • Madan Khatiwada,
  • Ryan Rachmad Nugraha,
  • Carine Dochez,
  • Harapan Harapan and ,
  • Kuswandewi Mutyara,
  • Laili Rahayuwati,
  • Maimun Syukri,
  • Eustachius Hagni Wardoyo,
  • Dewi Suryani and
  • Cissy Kartasasmita
  • + 6 authors+ 1 author

12 June 2024

The COVID-19 pandemic presented an unprecedented challenge to public health as well as an extraordinary burden on health systems worldwide. COVID-19 vaccines were attributed as a key tool to control the pandemic, with healthcare workers (HCWs) as a p...

(This article belongs to the Special Issue Vaccine Acceptance and Uptake: Insights from Behavioural and Social Sciences)
  • Review
  • Open Access
23 Citations
7,726 Views
27 Pages

Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status

  • Asmae Squalli Houssaini,
  • Salma Lamrabet,
  • Jean Paul Nshizirungu,
  • Nadia Senhaji and ,
  • Mohammed Sekal,
  • Mehdi Karkouri and
  • Sanae Bennis
  • + 2 authors+ 0 author

12 June 2024

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor. Standard treatments including surgical resection, radiotherapy, and chemotherapy, have failed to significantly improve the prognosis of glioblastoma patients. Currently, immu...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Systematic Review
  • Open Access
18 Citations
8,511 Views
26 Pages

12 June 2024

This systematic review of 54 cross-disciplinary peer-reviewed causal empirical studies helps public health officials, researchers, and healthcare professionals better comprehend the effects of fear appeals in vaccine promotional campaigns on message...

(This article belongs to the Special Issue Vaccination Attitudes, Perceptions, and Behaviors)
  • Article
  • Open Access
1 Citations
3,606 Views
16 Pages

Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine

  • Francisco Perez-Duran,
  • Fernando Calderon-Rico,
  • Luis Enrique Franco-Correa,
  • Alicia Gabriela Zamora-Aviles and ,
  • Roberto Ortega-Flores,
  • Daniel Durand-Herrera,
  • Alejandro Bravo-Patiño,
  • Ricarda Cortes-Vieyra,
  • Ilane Hernandez-Morales and
  • Rosa Elvira Nuñez-Anita
  • + 5 authors+ 0 author

11 June 2024

The aim of this study was to analyze the immunogenic response elicited in swine by two synthetic peptides derived from GP5 to understand the role of lineal B epitopes in the humoral and B-cell-mediated response against the porcine reproductive and re...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
16 Citations
4,830 Views
16 Pages

Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc)

  • Soowoo Back,
  • Bethany Knox,
  • Ciara Coakley,
  • Nicolas Deltour and ,
  • Emmanuelle Jacquot,
  • Hanaya Raad and
  • Elizabeth M. Garry
  • + 2 authors+ 0 author

11 June 2024

The mpox 2022 outbreak was declared a public health emergency in July 2022. In August 2022, the MVA–BN vaccine received emergency use authorization in the United States (US) to target at-risk groups. This study (EUPAS104386) used HealthVerity&r...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
8 Citations
3,456 Views
18 Pages

11 June 2024

The reported study compared the impact of four influence strategies (agency assignment, enhanced active choice, deviance regulation marking, and temporal framing) on English- and Spanish-speaking parents’ reported intention to vaccinate their c...

(This article belongs to the Special Issue Vaccine Strategies for HPV-Related Cancers)

of 3

XFacebookLinkedIn
Vaccines - ISSN 2076-393X